SCHEMBL21610467

SCHEMBL21610467

CC(C)C[C@@H](CN)c1ccc(Cl)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABBR2 O75899 6/20 0.53
GABBR1 Q9UBS5 6/20 0.53
LMNA P02545 3/20 0.53
CYP2C9 P11712 2/20 0.53
CYP1A2 P05177 2/20 0.53
THRB P10828 2/20 0.53
CYP3A4 P08684 2/20 0.53
TSHR P16473 2/20 0.53
ADORA3 P0DMS8 1/20 0.53
NFKB1 P19838 1/20 0.53
DRD3 P35462 1/20 0.53
BLM P54132 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C19 P33261 1/20 0.53
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
MAPT P10636 1/20 0.51
PMP22 Q01453 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3642655 1.00 GABBR2 (0.53) GABBR2GABBR1LMNACYP2C9CYP1A2
Hydrochloric Acid SCHEMBL3665299 0.98 GABBR2 (0.51) GABBR2GABBR1LMNACYP2C9CYP1A2
SCHEMBL5699189 0.89 TAAR1 (0.39) GABBR2GABBR1LMNACYP2C9CYP1A2
SCHEMBL10507284 0.83 GABBR2 (0.64) GABBR2GABBR1LMNACYP2C9CYP1A2
SCHEMBL9880973 0.82 GABBR2 (0.51) GABBR2GABBR1LMNACYP2C9CYP1A2
SCHEMBL3647917 0.82 ACHE (0.39) GABBR2GABBR1LMNACYP2C9CYP1A2
Hydrochloric Acid SCHEMBL10681987 0.81 GABBR2 (0.62) GABBR2GABBR1LMNACYP2C9CYP1A2
SCHEMBL19090082 0.79 TAAR1 (0.56) GABBR2GABBR1SLC6A3SLC6A4SLC6A2
SCHEMBL19294780 0.79 TAAR1 (0.56) GABBR2GABBR1SLC6A3SLC6A4SLC6A2
SCHEMBL2086299 0.79 TAAR1 (0.56) GABBR2GABBR1SLC6A3SLC6A4SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020002325-A1 COMPOUNDS SPERO THERAPEUTICS, INC. (US) 2020-01-02 WO disclosed